MIRM CIK: 1759425

Mirum Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
167
FY22:
190
FY23:
388
FY24:
393
FY25:
550
(positive)
Change from FY21 to FY25
millions USD
FY21:
128
FY22:
163
FY23:
259
FY24:
278
FY25:
293
Total assets
Change from FY21 to FY25
millions USD
FY21:
295
FY22:
353
FY23:
647
FY24:
671
FY25:
843

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
42.6
FY22:
64.7
FY23:
87.1
FY24:
127
FY25:
206
(negative)
Change from FY21 to FY25
millions USD
FY21:
132
FY22:
146
FY23:
311
FY24:
319
FY25:
322
(positive)
Change from FY21 to FY25
millions USD
FY21:
120
FY22:
142
FY23:
249
FY24:
226
FY25:
315
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
295
FY22:
353
FY23:
647
FY24:
671
FY25:
843

All amounts in millions USD Data source:SEC EDGAR